Fight against organ failure advances

January 13, 2014, Cardiff University
Fight against organ failure advances

(Medical Xpress)—The findings of a 20-year project undertaken by scientists committed to developing improved treatments for chronic kidney disease reveal a significant advance in our understanding of organ failure.

In a new paper published in the journal Immunity, researchers at the School of Medicine demonstrate a novel link that strongly implicates in organ damage resulting in organ failure. The research paves the way for a new generation of therapies that will protect organs from this type of damage and diagnostics capable of predicting patients susceptible to organ failure.

Critical for patients with kidney failure on peritoneal dialysis (the process uses the patient's peritoneum in the abdomen as a membrane across which fluids and dissolved substances - electrolytes, urea, glucose, albumin and other small molecules - are exchanged from the blood), the peritoneal cavity was used by scientists as a model to show how repeated episodes of infection result in inflammation triggering irreversible tissue damage.

"Damage to organs, such as the heart, lungs, liver, kidneys – in this case the – due to chronic inflammation is a significant healthcare issue. Tissue damage results in organ dysfunction and in some cases requiring transplantation or dialysis," said Professor Simon Jones, one of the lead authors of the study.

The other senior investigator of the paper, Professor Nick Topley, added:

"Preventing infection-induced damage to the peritoneal membrane is critical to the future success of . These findings are a major leap forward as they will allow us to target specific pathways for therapeutic benefit. This will enable us to treat patients for longer and more efficiently and target those who are most likely to develop problems."

Explore further: Peritoneal dialysis as an intervention for stroke patients

More information: Ceri A. Fielding, Gareth W. Jones, Rachel M. McLoughlin, Louise McLeod, Victoria J. Hammond, Javier Uceda, Anwen S. Williams, Mark Lambie, Thomas L. Foster, Chia-Te Liao, Christopher M. Rice, Claire J. Greenhill, Chantal S. Colmont, Emily Hams, Barbara Coles, Ann Kift-Morgan, Zarabeth Newton, Katherine J. Craig, John D. Williams, Geraint T. Williams, Simon J. Davies, Ian R. Humphreys, Valerie B. O'Donnell, Philip R. Taylor, Brendan J. Jenkins, Nicholas Topley, Simon A. Jones. "Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation," Immunity, Available online 9 January 2014, ISSN 1074-7613, dx.doi.org/10.1016/j.immuni.2013.10.022.

Related Stories

Peritoneal dialysis as an intervention for stroke patients

September 3, 2013
Ischemic stroke is characterized by an interruption of the blood supply to the brain, which can lead to brain damage and even death. Excess amounts of the excitatory neurotransmitter glutamate are released during stroke events ...

Landmark study provides key to improved survival in peritoneal dialysis patients

September 23, 2013
Clinicians and scientists from Keele and Cardiff universities have published data from a landmark study that explains why survival in patients on peritoneal dialysis is low.

Snapshot of dialysis: Who's getting treated at home?

February 2, 2012
Home-based dialysis treatments are on the rise in both the developing and developed worlds, but developed countries appear to be turning to them less often, according to a study appearing in an upcoming issue of the Journal ...

Surprising results for use of dialysis for kidney failure in developing world

April 26, 2012
Researchers at Lawson Health Research Institute have discovered that developing countries have faster growing rates of use of home-based dialysis (called peritoneal dialysis) for kidney failure than the developed world. Despite ...

Home dialysis gains momentum

December 19, 2013
Of the 400,000 people on dialysis in the United States only 6 percent to 7 percent are treated with home dialysis. Yet, patients are significantly more likely to choose home dialysis if they are given that option. Home dialysis ...

Recommended for you

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

How the immune system's key organ regenerates itself

January 15, 2018
With advances in cancer immunotherapy splashing across headlines, the immune system's powerful cancer assassins—T cells—have become dinner-table conversation. But hiding in plain sight behind that "T" is the organ from ...

Immunosuppressive cells in newborns play important role in controlling inflammation in early life

January 15, 2018
New research led by The Wistar Institute, in collaboration with Sun Yat-sen University in China, has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing ...

Memory loss from West Nile virus may be preventable

January 15, 2018
More than 10,000 people in the United States are living with memory loss and other persistent neurological problems that occur after West Nile virus infects the brain.

Mould discovery in lungs paves way for helping hard to treat asthma

January 15, 2018
A team at The University of Manchester have found that in a minority of patients they studied, a standard treatment for asthma—oral steroids—was associated with increased levels of the treatable mould Aspergillus in the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.